Emerge Health

news

news
 
Posted 01-Dec-2017

ASACOL® (mesalazine) PBS Listing

EMERGE HEALTH PTY LTD, a specialty medicines company, today announced the PBS listing of ASACOL 800mg mesalazine enteric-coated tablets [AUST R 261420], effective as of the 1st of December 2017.

ASACOL is indicated for the treatment of mild to moderate ulcerative colitis and maintenance of remission in adults.

All hospital pharmacies and wholesalers will be able to order ASACOL through Emerge Health.

All orders, medical and product enquiries and adverse event reports concerning ASACOL should be directed to Emerge Health on:

Direct: (03) 9077 4486
Fax: (03) 8672 0792
E-mail: customerservice@emergehealth.com.au
Mail: Emerge Health
Suite 3, Level 1, 2 Theatre Place
Canterbury VIC 3126 Australia

In case of emergency please call (03) 9939 1482.

If you have any questions regarding this change, please contact Emerge Health on (03) 9077 4486.

To read a copy of the ASACOL PI, click here.

PBS Information: Authority required (STREAMLINED) for the treatment of Ulcerative Colitis. Patient must have had a documented hypersensitivity reaction to a sulphonamide OR Patient must be intolerant to sulfasalazine.

PBS Streamline Code for prescribing: 4824